top of page
2.png
Apply to Participate

Participating in clinical research studies offers individuals a valuable chance to access free medical services while gaining insights into their health conditions. We also welcome healthy volunteers to join our clinical trials. Typically, volunteers are compensated for their time and travel expenses. For more information on participating in clinical, feel free to reach out to us.

  • Whatsapp

Why Participate in a clinical trial

icon car

You may receive compensation for your time and travel during your participation.

icon medical

The pharmaceutical company funds the research studies, making it unnecessary.

icon person

You will be able to connect with our medical research team throughout the study.

icon stop

You can withdraw your consent or choose to stop participating in the study at any time.

icon lock

Your information is kept private, secure, and is never shared without your consent.

practitioner showing

Here are motivations for taking part in a clinical trial.

Clinical trials are essential for testing new treatments prior to their release to the public. Although participants cannot guarantee receiving the treatment, they often enjoy numerous other advantages. They monitored by board-certified physicians, gain insights into their condition, receive diagnostic tests and lab work for, and contribute to medical advancement by supplying valuable data for research. Furthermore, participants frequently receive compensation for their time and involvement.

Enrolling Clinical Research Studies
Poster VENTURA-7
  • Whatsapp
Depression
Depression research wants to bring light back to your view.

Learn about the VENTURA-7 research study for adults with major depressive disorder (MDD) who experience a loss of interest or pleasure. This study is evaluating an oral investigational medication that is taken in addition to your current antidepressant medication to which you have had an unsatisfactory response.

The main purpose of this study is to see if the once daily oral study medication is safe and effective for depression symptoms when it is taken in addition to your current antidepressant medication.

To potentially be in this study, you must:

 

  • Be 18 to 64 years of age

  • Have been diagnosed with depression

  • Be experiencing depressive symptoms, including loss of interest or the ability to feel pleasure, despite currently taking antidepressant medication

Poster NORA520
Postpartum depression
A research study is evaluating an investigational drug, NORA520, to determine if it is safe and effective in treating adults with severe postpartum depression. Study participants who qualify and enroll in this study will be asked to participate for up to 60 days, composed of 1 screening visit, 3 night in-patient stay, and 2 follow-up visits. Participants will be randomly assigned (like the flip of a coin) to receive either the investigational drug NORA520 or a placebo.

To participate in this study, participants*:

 

  • Must be female ages 18-45 (inclusive)

  • Must have been diagnosed with postpartum depression, with a
    depressive episode beginning between the 3rd trimester and 4th
    week postpartum

  • Must have had a baby within the last 9 months

Other eligibility criteria apply. Participants receive investigational drug at no cost.
Reimbursement for study-related time, travel, and childcare may be available.

Poster POLARIS-AD
Alzheimer’s Disease
Learn more about the POLARIS-AD study, for people in the early stages
of Alzheimer’s Disease (AD).

POLARIS-AD will examine whether a study drug called AR1001 may help slow AD progression.
You may be able to join this study if you are 55-90 years old and have symptoms consistent with the early
stages of AD. Other study requirements apply.
Symptoms in the early stages of AD include difficulties with memory, planning, and organization. Many
people in these stages also find it challenging to learn new information, follow directions, and come up with
the right words to describe something. Nonetheless, most can still function independently in daily life.

Study participants receive at no cost:

  • Access to the study drug

  • For the first year of the study, half of participants will receive placebo, which has no active ingredients.

  • For the next year, all participants will be able to receive the study drug.

  • Study support and monitoring by a healthcare team

  • The opportunity to help advance AD research

Poster ALTO
Depression disorder
Current antidepressant not working for you? Let us help.

You may qualify for a clinical study in depression, including a novel investigational therapeutic and compensation for your time. Our study doctors are studying how your brain's unique biology impacts treatment response, looking at key biomarkers across sleep, cognition and emotion.

To join the Alto study:

  • You must be 18 years or older

  • Have a diagnosis of major depressive disorder (MDD)

  • Be on an antidepressant medication.

Sin-título-1.png
Struggling with opioid use disorder
Struggling with opioid use disorder? Learn more about a clinical trial.

We are conducting a research study to better understand and develop effective treatments for opioid use disorder. Your participation can make a significant difference in the fight against opioid addiction. If you are struggling with opioid use disorder, you may qualify for a paid clinical trial. Your privacy is a priority and all Information collected will be kept confidential.

Eligible Participants Are:

  • 18 – 65 years of age

  • Able to stay overnight in our facility for multiple nights

  • Additional criteria may apply

Pipeline:

bottom of page